EIB Group, EC, IFC back Africa's first multi-vaccine site

The European Investment Bank (EIB) Group, the European Commission, and the International Finance Corporation (IFC) are jointly supporting Biovac's project to build Africa’s first end-to-end multi-vaccine manufacturing site. This partnership aims to enhance vaccine production capacity and health security on the African continent. The investment signifies the EU's commitment to global health initiatives and fostering sustainable development in partner regions.

Read source